Cargando…
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
SIMPLE SUMMARY: Several anti-angiogenic drugs have been approved for cancer treatment, alone or in combination with other anti-tumoral agents. Angiogenesis inhibitors cause drug resistance, metastasis formation, and reduced delivery of chemotherapeutic agents, as a consequence of decrease of tumor v...
Autores principales: | Ribatti, Domenico, Solimando, Antonio Giovanni, Pezzella, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304542/ https://www.ncbi.nlm.nih.gov/pubmed/34298648 http://dx.doi.org/10.3390/cancers13143433 |
Ejemplares similares
-
Diabetes and climate change: breaking the vicious cycle
Publicado: (2023) -
Anti‐Oxidative and Anti‐Inflammatory Micelles: Break the Dry Eye Vicious Cycle
por: Li, Su, et al.
Publicado: (2022) -
Transgenerational Transmission of Non-communicable Diseases: How to Break the Vicious Cycle?
por: Bronson, Stephen C, et al.
Publicado: (2021) -
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
por: Solimando, Antonio Giovanni, et al.
Publicado: (2020) -
Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages
por: Su, Shicheng, et al.
Publicado: (2014)